With a revenue increase of 30.89% in the first quarter 2026, year on year to cumulative value of $196 million, Geron's revenue per employee grew on a trailing twelve months basis to $ 759,136, this marks a new company high.
Within the Healthcare sector Employees of 73 other companies have achieved higher revenue per employee. While Geron's total ranking has deteriorated compared to the previous quarter from 87 to 757. Geron has 258 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GERN Revenue per Employee	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Revenue Change	30.89 %	1.53 %	67.05 %	5459.64 %	12927.3 %
Sales per Employee (TTM) $	759,136	711,717	708,930	635,457	448,814
GERN's Total Ranking	# 757	# 87	# 98	# 88	# 93
Seq. Revenue Change	8.54 %	1.12 %	-3.69 %	23.82 %	-15.81 %

GERN Company Profile >> Back to GERN Efficiency Comparisons >> Compare GERN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 51
Healthcare Sector	# 74
Overall Market	# 757

Revenue per Employee Statistics
High	Average	Low
$ 759,136	$ 99,308	$ -15,713
(Mar 31 2026)		(Jun 30 2018)

Financial Statements
Geron's Revenue MRQ	$ 52 Millions	Visit GERN's Income Statement
Geron's Revenues TTM	$ 196 Millions	Visit GERN's aggregate revenue growth
What are GERN's Sales?		Visit GERN's Sales by Segment

Other Ratios
Geron's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GERN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GERN's Competitors
Revenue per Employee for GERN's Suppliers
Revenue per Employee for GERN's Customers

You may also want to know
GERN's Sales Growth Rates	GERN's Pe Price to earnings ratio	GERN's Receivables Turnover Ratio	GERN's Stock Quote
GERN's Net Income Growth Rates	GERN's Ps Price to Sales ratio	GERN's Sales per Employee	GERN's Asset Turnover Ratio
GERN's Net Margin	GERN's Pb Price to Book ratio	GERN's Financial Strength Ratios	GERN's Dividend Payout Ratio

Date modified: 2026-08-30T14:48:47+00:00

Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Mar 31 2026	Number of Employees Mar 31 2026
Biogen Inc	1,324,986.67	$ 9,937.400 Million	7,500
Lantheus Holdings Inc	1,295,200.34	$ 1,545.174 Million	1,193
Indivior Pharmaceuticals Inc	1,292,000.00	$ 1,292.000 Million	1,000
Puma Biotechnology Inc	1,269,150.84	$ 227.178 Million	179
Madrigal Pharmaceuticals Inc	1,237,693.99	$ 1,132.490 Million	915
Theravance Biopharma inc	1,219,722.22	$ 109.775 Million	90
Akebia Therapeutics Inc	1,197,958.76	$ 232.404 Million	194
Supernus Pharmaceuticals inc	1,191,461.66	$ 776.833 Million	652
Arcutis Biotherapeutics Inc	1,174,079.10	$ 415.624 Million	354
Heron Therapeutics Inc	1,173,312.50	$ 150.184 Million	128
Cue Biopharma Inc	1,128,655.17	$ 32.731 Million	29
Journey Medical Corp	1,115,172.41	$ 64.680 Million	58
Abbvie Inc	1,102,087.72	$ 62,819.000 Million	57,000
Travere Therapeutics Inc	1,078,863.18	$ 536.195 Million	497
Corcept Therapeutics Inc	1,053,556.16	$ 769.096 Million	730
Biomarin Pharmaceutical Inc	1,006,617.82	$ 3,242.316 Million	3,221
Scilex Holding Company	995,941.18	$ 33.862 Million	34
Coya Therapeutics Inc	992,377.00	$ 7.939 Million	8
Sanara Medtech Inc	989,563.23	$ 106.873 Million	108
Assembly Biosciences Inc	973,931.51	$ 71.097 Million	73
Hims and Hers Health Inc	970,301.39	$ 2,369.476 Million	2,442
Regeneron Pharmaceuticals Inc	968,176.51	$ 14,919.600 Million	15,410
Ani Pharmaceuticals Inc	952,274.23	$ 923.706 Million	970
Integrated Biopharma Inc	944,820.00	$ 47.241 Million	50
Evolus Inc	905,236.53	$ 302.349 Million	334
Pacira Biosciences inc	886,446.32	$ 734.864 Million	829
Keenova Therapeutics Plc	883,125.00	$ 1,413.000 Million	1,600
Nektar Therapeutics	883,063.49	$ 55.633 Million	63
Merck and Co Inc	876,906.67	$ 65,768.000 Million	75,000
Arrowhead Pharmaceuticals Inc	874,836.85	$ 622.009 Million	711

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.